Achtergrond afbeelding Achtergrond afbeelding darkmode

Towards dynamic personalized cancer screening: integrating risk-factors, test results and natural-history modeling.

Producten

Titel: Stage- and histology-specific sensitivity for the detection of lung cancer of the NELSON screening protocol—A modeling study
Auteur: Koen de Nijs, Kevin ten Haaf, Juul Hubert, Dana Moldovanu, Carlijn M. van der Aalst, Harry J. M. Groen, Pim A. de Jong, Marjolein A. Heuvelmans, Matthijs Oudkerk, Harry J. de Koning
Magazine: International Journal of Cancer
Begin- en eindpagina: 1-11
Link: https://onlinelibrary.wiley.com/doi/10.1002/ijc.70045
Titel: Performance of smoking duration-based lung cancer screening eligibility criteria: a comparative modeling study
Auteur: Pianpian Cao, Koen De Nijs, Justin Lee, Jihyoun Jeon, Harry J De Koning, Sylvia K Plevritis, Kevin Ten Haaf, Summer S Han, Rafael Meza
Magazine: Journal of the National Cancer Institute
Link: https://academic.oup.com/jnci/advance-article/doi/10.1093/jnci/djag018/8439748?login=true#554592792
Titel: A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trials
Auteur: Welz M, van der Aalst CM, Alfons A, Naghi AA, Heuvelmans MA, Groen HJM, de Jong, Aerts J, Oudkerk M, de Koning HJ, ten Haaf K.
Magazine: Nature Communications (in press)
Titel: Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung Cancer
Auteur: de Nijs K, de Koning HJ, Cao P, Mahmoudi H, Diasparra M, Garner R, Jeon J, Yong JHE, Meza R, ten Haaf K.
Magazine: JAMA Network Open
Link: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2836784
Titel: Influence of changing patterns in lung cancer treatment and survival on the cost-effectiveness of CT screening: a modeling study
Auteur: Koen de Nijs, Kevin Ten Haaf, Dana Moldovanu, Juul Hubert, Isabelle van den Bosch, Anouk Eijkelboom, Carlijn van der Aalst Harry J de Koning
Magazine: EClinicalMedicine .
Link: https://www.sciencedirect.com/science/article/pii/S2589537025003785?via%3Dihub
Titel: The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations
Auteur: Ten Haaf K, de Nijs K, Simoni G, Alban A, Cao P, Sun Z, Yong J, Jeon J, Toumazis I, Han SS, Gazelle GS, Kong CY, Plevritis SK, Meza R, de Koning HJ
Magazine: Medical Decision Making
Link: https://journals.sagepub.com/doi/10.1177/0272989X241249182
Titel: Welz M., ten Haaf K., Alfons A. predmod: Predictive modeling for heterogeneous treatment effects. 2023. R package:
Titel: Heineken Young Scientists Award in the Medical/Biomedical Sciences field 2024
Link: https://www.heinekenprizes.org/portfolio-items/kevin-ten-haaf/?portfolioCats=318
Titel: OA17.06 Impact of Using Smoking Duration in Place of Pack-Years as Eligibility Criteria for Lung Cancer Screening to Reduce Racial and Ethnic Disparities
Auteur: Su CC, Ding VY, ten Haaf K, Wu JT, Freedman ND, Backhus LM, Leung AN, Lui NS, Haiman CA, Park SL, Neal JW, Meza R, Tammema¨gi MC, Cheng I, Le Marchand L, Wakelee HA, Choi E, Han SS.
Titel: MTE02.02 Considering Life Expectancy in the Selection of Individuals for Lung Cancer Screening
Auteur: Kevin ten Haaf
Link: https://cattendee.abstractsonline.com/meeting/20598/Session/16
Titel: OA05.04 A Comparison of Stage- and Histology-Specific CT Sensitivity in the NELSON Trial and the NLST
Auteur: de Nijs K, ten Haaf K, van der Aalst CM, Oudkerk M, de Koning HJ
Titel: Personalisatie van bevolkingsonderzoeken is essentieel voor toekomstbestendige vroege opsporing
Auteur: Kevin ten Haaf
Link: https://www.avondwenm.nl/site-versions/release/club-assistent/upload/avondwenm/content/AVW_tafel_stellingen_24_6.pdf
Titel: P4.04D.04 Efficiency of the Annual CT Screening Interval for Those at a Lower Risk of Lung Cancer - A CISNET Comparative Modelling Study
Auteur: de Nijs K, de Koning HJ, Cao P, Mahmoudi H, Diasparra M, Garner R, Jeon J, Feuer EJ, Yong JHE, Gazelle S, Meza R, ten Haaf K.
Titel: The optimal upper age limit for breast cancer screening, accounting for differences in comorbidity status and smoking behaviour
Auteur: Dibbets S, ten Haaf K, Heijnsdijk E, Otten H, Broeders M, de Koning H, van Ravesteyn N

Kenmerken

  • Projectnummer:
    09150161910060
  • Looptijd: 100%
    Looptijd: 100 %
    2021
    2025
  • Gerelateerde programma's:
  • Gerelateerde subsidieronde:
  • Projectleider en penvoerder:
    K. ten Haaf
  • Verantwoordelijke organisatie:
    Erasmus Medisch Centrum